1. Home
  2. PRTA vs PLAY Comparison

PRTA vs PLAY Comparison

Compare PRTA & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • PLAY
  • Stock Information
  • Founded
  • PRTA 2012
  • PLAY 1982
  • Country
  • PRTA Ireland
  • PLAY United States
  • Employees
  • PRTA N/A
  • PLAY N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • PLAY Restaurants
  • Sector
  • PRTA Health Care
  • PLAY Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • PLAY Nasdaq
  • Market Cap
  • PRTA 809.8M
  • PLAY 804.3M
  • IPO Year
  • PRTA N/A
  • PLAY 1995
  • Fundamental
  • Price
  • PRTA $12.14
  • PLAY $18.49
  • Analyst Decision
  • PRTA Buy
  • PLAY Buy
  • Analyst Count
  • PRTA 9
  • PLAY 7
  • Target Price
  • PRTA $54.57
  • PLAY $50.00
  • AVG Volume (30 Days)
  • PRTA 454.8K
  • PLAY 1.2M
  • Earning Date
  • PRTA 05-07-2025
  • PLAY 04-07-2025
  • Dividend Yield
  • PRTA N/A
  • PLAY N/A
  • EPS Growth
  • PRTA N/A
  • PLAY N/A
  • EPS
  • PRTA N/A
  • PLAY 2.10
  • Revenue
  • PRTA $135,157,000.00
  • PLAY $2,197,200,000.00
  • Revenue This Year
  • PRTA N/A
  • PLAY $0.21
  • Revenue Next Year
  • PRTA $131.75
  • PLAY $4.62
  • P/E Ratio
  • PRTA N/A
  • PLAY $8.81
  • Revenue Growth
  • PRTA 47.92
  • PLAY 1.25
  • 52 Week Low
  • PRTA $11.42
  • PLAY $17.02
  • 52 Week High
  • PRTA $25.42
  • PLAY $69.82
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 38.46
  • PLAY 41.65
  • Support Level
  • PRTA $11.42
  • PLAY $17.13
  • Resistance Level
  • PRTA $13.52
  • PLAY $21.22
  • Average True Range (ATR)
  • PRTA 0.75
  • PLAY 1.16
  • MACD
  • PRTA -0.12
  • PLAY 0.13
  • Stochastic Oscillator
  • PRTA 24.66
  • PLAY 33.25

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About PLAY Dave & Buster's Entertainment Inc.

Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.

Share on Social Networks: